Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Tyrer

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Clinical and Experimental Pharmacology & Physiology|January 1, 1979
The comparative bioavailability of carbamazepine in 100 mg and 200 mg tabletsG A Smith, W D Hooper, J H Tyrer, et al.
Archives of Neurology|July 1, 1974
Diphenylhydantoin concentrations in salivaF Bochner, W D Hooper, J M Sutherland, et al.
Clinical and Experimental Neurology|January 1, 1985
Valproate hepatotoxicity: a review and report of two instances in adultsR G Dickinson, M L Bassett, J Searle, et al.
Journal of Chromatography|August 8, 1980
Electron-capture gas chromatographic assay for metoclopramide in plasmaL M Ross-Lee, M J Eadie, F Bochner, et al.
British Journal of Clinical Pharmacology|September 1, 1978
Disopyramide pharmacokinetics and bioavailabilityD K Dubetz, N N Brown, W D Hooper, et al.
The Medical Journal of Australia|February 26, 1972
Blood phenytoin concentrations produced by ingestion of three different phenytoin preparationsD B Appleton, M J Eadie, W D Hooper, et al.
European Journal of Clinical Pharmacology|December 28, 1977
The pharmacokinetics of carbamazepineL M Cotter, M J Eadie, W D Hooper, et al.
Clinical Pharmacology and Therapeutics|April 1, 1975
Plasma protein binding of carbamazepineW D Hooper, D K Dubetz, F Bochner, et al.
Toxicology and Applied Pharmacology|April 1, 1973
Possible acute liver toxicity from the hypolipidemic agent 1-methyl-4-piperidyl-bis(p-chlorophenoxy)-acetateF Bochner, B E Cham, M J Eadie, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Clinical and Experimental Pharmacology & Physiology|January 1, 1979
The comparative bioavailability of carbamazepine in 100 mg and 200 mg tabletsG A Smith, W D Hooper, J H Tyrer, et al.
Archives of Neurology|July 1, 1974
Diphenylhydantoin concentrations in salivaF Bochner, W D Hooper, J M Sutherland, et al.
Clinical and Experimental Neurology|January 1, 1985
Valproate hepatotoxicity: a review and report of two instances in adultsR G Dickinson, M L Bassett, J Searle, et al.
Journal of Chromatography|August 8, 1980
Electron-capture gas chromatographic assay for metoclopramide in plasmaL M Ross-Lee, M J Eadie, F Bochner, et al.
British Journal of Clinical Pharmacology|September 1, 1978
Disopyramide pharmacokinetics and bioavailabilityD K Dubetz, N N Brown, W D Hooper, et al.
The Medical Journal of Australia|February 26, 1972
Blood phenytoin concentrations produced by ingestion of three different phenytoin preparationsD B Appleton, M J Eadie, W D Hooper, et al.
European Journal of Clinical Pharmacology|December 28, 1977
The pharmacokinetics of carbamazepineL M Cotter, M J Eadie, W D Hooper, et al.
Clinical Pharmacology and Therapeutics|April 1, 1975
Plasma protein binding of carbamazepineW D Hooper, D K Dubetz, F Bochner, et al.
Toxicology and Applied Pharmacology|April 1, 1973
Possible acute liver toxicity from the hypolipidemic agent 1-methyl-4-piperidyl-bis(p-chlorophenoxy)-acetateF Bochner, B E Cham, M J Eadie, et al.
Pageof 7